Tech Company Financing Transactions

Orchestra BioMed Funding Round

On 7/16/2019, Orchestra BioMed raised $34 million in Series B funding from Perceptive Advisors, RTW Investments and Soleus Capital.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B

Perceptive Advisors (Lead Investor)

RTW Investments (Lead Investor)

Soleus Capital (Lead Investor)

SternAegis Ventures


Proceeds Purpose
Proceeds from the financing will be used to accelerate and expand development of Orchestra BioMed's lead and pipeline assets, including BackBeat Cardiac Neuromodulation Therapy (CNT) for hypertension.

Company Information

Company Status
Private & Independent
Mailing Address
150 Union Square Dr.
New Hope, PA 18938
Email Address
Orchestra BioMed, Inc. is a biomedical innovation company focused on developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions.
Orchestra BioMed LinkedIn Company Profile
Social Media
Orchestra BioMed Company Twitter Account
Company News
Orchestra BioMed News
Orchestra BioMed on Facebook
Orchestra BioMed on YouTube

Management Team

Email & Social
Chief Executive Officer
David Hochman
  David Hochman LinkedIn Profile  David Hochman Twitter Account  David Hochman News  David Hochman on Facebook
Chief Financial Officer
Evan Ballantyne
  Evan Ballantyne LinkedIn Profile  Evan Ballantyne Twitter Account  Evan Ballantyne News  Evan Ballantyne on Facebook
Chief Medical Officer
Dennis Donohoe
  Dennis Donohoe LinkedIn Profile  Dennis Donohoe Twitter Account  Dennis Donohoe News  Dennis Donohoe on Facebook
Chief Medical Officer
Steven Evans
  Steven Evans LinkedIn Profile  Steven Evans Twitter Account  Steven Evans News  Steven Evans on Facebook
Chief Operating Officer
Darren Sherman
  Darren Sherman LinkedIn Profile  Darren Sherman Twitter Account  Darren Sherman News  Darren Sherman on Facebook
Chief Technical Officer
Yuval Mika
  Yuval Mika LinkedIn Profile  Yuval Mika Twitter Account  Yuval Mika News  Yuval Mika on Facebook
VP - Marketing
Inessa Wheeler
  Inessa Wheeler LinkedIn Profile  Inessa Wheeler Twitter Account  Inessa Wheeler News  Inessa Wheeler on Facebook
VP - R & D
Ziv Belsky
  Ziv Belsky LinkedIn Profile  Ziv Belsky Twitter Account  Ziv Belsky News  Ziv Belsky on Facebook
VP - Regulatory Affairs
Eileen Bailey
  Eileen Bailey LinkedIn Profile  Eileen Bailey Twitter Account  Eileen Bailey News  Eileen Bailey on Facebook
VP - Regulatory Affairs
William Baumbach
  William Baumbach LinkedIn Profile  William Baumbach Twitter Account  William Baumbach News  William Baumbach on Facebook



Browse more venture capital transactions:

Prev: 7/16/2019: DefenseStorm venture capital transaction
Next: 7/16/2019: Recursion Pharmaceuticals venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary